John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Hurco Companies Inc
HURC
$147M
| $559K | ﹤0.01% |
17,734
-11,500
| -39% | -$373K |
|
1952
First Bancorp
FBNC
$2.65B
| $558K | ﹤0.01% |
13,362
-14,539
| -52% | -$649K |
|
1953
Red Violet
RDVT
$1.11B
| $555K | ﹤0.01% |
19,472
+6,895
| +55% | +$194K |
|
1954
Alibaba
BABA
$286B
| $554K | ﹤0.01% |
5,088
-1,268,429
| -100% | -$146M |
|
1955
Perella Weinberg Partners
PWP
$1.23B
| $554K | ﹤0.01% |
58,658
-35,571
| -38% | -$379K |
|
1956
Aegon
AEG
$13.6B
| $553K | ﹤0.01% |
+109,250
| New | +$552K |
|
1957
Ribbon Communications
RBBN
$368M
| $553K | ﹤0.01% |
+179,073
| New | +$734K |
|
1958
Oceaneering
OII
$4.97B
| $552K | ﹤0.01% |
+36,412
| New | +$524K |
|
1959
Eagle Bancorp
EGBN
$844M
| $551K | ﹤0.01% |
9,665
-3,833
| -28% | -$229K |
|
1960
Phathom Pharmaceuticals
PHAT
$712M
| $547K | ﹤0.01% |
40,216
-23,580
| -37% | -$381K |
|
1961
Sabra Healthcare REIT
SBRA
$5.32B
| $547K | ﹤0.01% |
+36,730
| New | +$503K |
|
1962
FirstService
FSV
$6.29B
| $546K | ﹤0.01% |
3,769
-69,478
| -95% | -$10.6M |
|
1963
PAVmed
PAVM
$42.2M
| $546K | ﹤0.01% |
918
-2,984
| -76% | -$2.22M |
|
|
ADAP
1964
DELISTED
Adaptimmune Therapeutics
ADAP
| $544K | ﹤0.01% |
+263,960
| New | +$712K |
|
1965
Capitol Federal Financial
CFFN
$1.05B
| $543K | ﹤0.01% |
+49,887
| New | +$557K |
|
1966
First Mid Bancshares
FMBH
$1.33B
| $541K | ﹤0.01% |
14,043
+8,543
| +155% | +$351K |
|
1967
Utah Medical Products
UTMD
$226M
| $539K | ﹤0.01% |
5,996
+3,097
| +107% | +$285K |
|
|
MILE
1968
DELISTED
Metromile, Inc. Common Stock
MILE
| $539K | ﹤0.01% |
408,132
-174,983
| -30% | -$253K |
|
1969
Lloyds Banking Group
LYG
$88.1B
| $538K | ﹤0.01% |
223,266
+169,000
| +311% | +$449K |
|
|
GOCO
1970
DELISTED
GoHealth
GOCO
| $537K | ﹤0.01% |
30,313
-39,484
| -57% | -$1.23M |
|
1971
Everspin Technologies
MRAM
$429M
| $537K | ﹤0.01% |
61,604
-299,351
| -83% | -$2.87M |
|
1972
RBB Bancorp
RBB
$448M
| $537K | ﹤0.01% |
22,865
+640
| +3% | +$16.4K |
|
1973
Harrow
HROW
$1.55B
| $536K | ﹤0.01% |
78,557
-53,044
| -40% | -$409K |
|
1974
United Fire Group
UFCS
$1.38B
| $536K | ﹤0.01% |
17,249
-1,048
| -6% | -$27.8K |
|
1975
Global Net Lease
GNL
$2.14B
| $535K | ﹤0.01% |
34,007
-41,321
| -55% | -$607K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.